哈尔滨耳结构放大模型荆州针刺训练手臂模型,永州中心静脉穿刺插管模型,广州战场急救创伤护理技术综合训练模拟人,贵州小儿手臂静脉穿刺训练模型,贵阳高级全功能护理人训练模型（男性）,六盘水高级全功能新生儿模拟人,2倍大刷牙模型

The decades-old sexual assault and murder of a young girl has been solved, thanks to DNA and genealogy records.In September 1982, 8-year-old Kelly Prosser was walking home from school in Columbus, Ohio. Prosser never made it home, and her body was found in a cornfield two days later after her raincoat was spotted.The case went unsolved for decades.DNA evidence from the items collected at the time was entered into CODIS in 2014. There were no hits.Friday, Prosser’s killer was identified as Harold Warren Jarrell, with the help of DNA evidence and genealogical research. Jarrell is now deceased, living relatives helped officers confirm details about Jarrell’s involvement.In 1977, Jarrell was charged with abducting a girl on the north side of Columbus, he was released in early 1982. Jarrell was never mentioned in Prosser’s case file. 848

The COVID-19 pandemic has hit people of color particularly hard, and one new study says that may be because of racial disparities in treating high blood pressure.According to the American Heart Association's Scientific Sessions, one-third of disparities in treatment may be the result of racial inequalities in prescribing or increasing the dosage of new medications used in treating high blood pressure.The study found that blood pressure control rates are lower in Black patients compared to other racial groups. Black patients also had more missed opportunities for treatment and missed more clinic appointments."A doctor might think a patient is less likely less able to afford medications, and because of that, they choose to not prescribe a certain medication," said Dr. Valy Fontil, an assistant professor of medicine at UCSF and one of the researchers involved in the study. "Or, they might know this person doesn't have transportation to the clinic, and so sometimes it might even be well-intentioned."Fontil says more standardized treatment protocols would help eliminate the disparities and prevent missed opportunities to get someone the medication they need."Sometimes people present, and the main thing that they're there for is not for the blood pressure," he said. "So, the clinician just sort of kind of might ignore the blood pressure. So automating these sort of standardized treatments would tell the clinician that they — even if the patient's not here for blood pressure — you have to address it in some way."Previous studies have also shown Black patients have more apprehension about why someone is giving them more medication. Fontil says one solution is having the patient be part of the treatment decision making.Fontil adds that the increasing number of virtual visits for blood pressure issues could make the racial disparities even worse. 1876

The Centers for Disease Control and Prevention ensemble forecast projects will be 207,000 to 218,000 COVID-19 deaths in the United States by Oct. 10.As of Thursday, 197,364 Americans have already perished from the coronavirus, according to Johns Hopkins University.With the new forecast, that means approximately 9,600 to 20,600 more people could die in the next three weeks.Two previous ensemble forecasts have already been published: one Sept. 3 and another on Sept. 10.The Sept. 3 forecast projected up to 211,000 deaths by Sept. 26. The Sept. 11 one projected up to 217,000 deaths by Oct. 3. 603

The FDA's Vaccines and Related Biological Products Advisory Committee panel has endorsed a second COVID-19 vaccine in the United States.Now the FDA is expected to act quickly to authorize the Moderna vaccine for emergency use and keep it on schedule to be distributed to patients across the country as early next week.The panel voted 20 yeses and one abstain.WATCH RECAP:With the panel recommending EUA, the FDA as a whole would then need to file its own EUA approval. The final step would be a formal recommendation from the Centers for Disease Control and Prevention that Americans should receive the vaccine.Last Thursday, the committee voted in favor of granting EUA to Pfizer's COVID-19 vaccine. By Monday, it was being administered across the country.The panel's meeting comes days after a key FDA report upheld the safety and efficacy results of the Moderna vaccine's Phase III trials. Those statistics showed that the vaccine was 95% effective with no severe side-effects."FDA has determined that the Sponsor has provided adequate information to ensure the vaccine's quality and consistency for authorization of the product under an EUA," the report said.An approval of Moderna's vaccine would immediately boost the supply levels of COVID-19 vaccines in the U.S. Millions of doses are ready to be shipped across the country as soon as approval is granted.The arrival of COVID-19 vaccines comes amid the bleakest stretch to date in the COVID-19 pandemic. The U.S. is currently seeing the highest level of new cases (213.000) and deaths (2,500) each day, according to seven-day rolling averages totaled by the COVID Tracking Project. More Americans than ever are also battling the virus in a hospital (113,000). 1725

The Dow Jones Industrial Average dropped several hundred points upon opening Friday morning hours after President Donald Trump confirmed he had been diagnosed with COVID-19.The Dow Jones Industrial Average sank more than 200 points immediately upon opening at 9:30 ET Friday morning. The market remains down about 150 points as of 10 a.m. ET on Friday. 360